Originally published at: https://developer.nvidia.com/blog/inception-spotlight-synvivia-developing-a-protein-switch-for-covid-19/
This week at GTC 2020, synthetic biology startup Synvivia showcased protein switches being developed to control engineered organisms and aid in drug discovery for COVID-19. The full session is available in the GTC catalog to view on-demand. Synvivia uses GPU-accelerated molecular dynamics simulations to design protein molecule interactions and was able to observe potential additive…